Celldex Therapeutics CEO Anthony Marucci's 2021 pay jumps 101% to $6M

Celldex Therapeutics reports 2021 executive compensation

By ExecPay News

Published: April 26, 2022

Celldex Therapeutics reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, five executives at Celldex Therapeutics received on average a compensation package of $3.1M, a 88% increase compared to previous year.
Average pay of disclosed executives at Celldex Therapeutics
Anthony S. Marucci, Chief Executive Officer, received $6M in total, which increased by 101% compared to 2020. 81% of Marucci's compensation, or $4.9M, was in option awards. Marucci also received $490K in bonus, $669K in salary, as well as $18K in other compensation.
For fiscal year 2021, the median employee pay was $195,006 at Celldex Therapeutics. Therefore, the ratio of Anthony S. Marucci's pay to the median employee pay was 31 to one.
Tibor Keler., Chief Scientific Officer, received a compensation package of $2.7M, which increased by 80% compared to previous year. 73% of the compensation package, or $2M, was in option awards.
Sam Martin, Chief Financial Officer, earned $2.5M in 2021, a 78% increase compared to previous year.
Diane C. Young, Chief Medical Officer, received $2.2M in 2021.
Freddy Jimenez, General Counsel, earned $2.2M in 2021.

Related executives

Anthony Marucci

Celldex Therapeutics

Chief Executive Officer

Tibor Keler

Celldex Therapeutics

Chief Scientific Officer

Freddy Jimenez

Celldex Therapeutics

General Counsel

Sam Martin

Celldex Therapeutics

Chief Financial Officer

Diane Young

Celldex Therapeutics

Chief Medical Officer

You may also like

Source: SEC filing on April 26, 2022.